URIC ACID AND TISSUE REPAIR
- By Medicine Mates
- Posted 1085 days ago
On-line version ISSN 2317-6326
ABCD, arq. bras. cir. dig. vol.28 no.4 São Paulo Nov./Dec. 2015
URIC ACID AND TISSUE REPAIR
1Post-Graduate Program in Principles of Surgery, Evangelic Faculty of Paraná/University Evangelic Hospital of Curitiba/Medical Research Institute, Curitiba, PR, Brazil
Uric acid, a metabolic product of purines, may exert a role in tissue healing. In this review we will explore its role as an alarm initiating the inflammatory process that is necessary for tissue repair, as a scavenger of oxygen free radicals, as a mobilizer of progenitor endothelial cells and as supporter of adaptive immune system.
Key words: Acid; Cicatrization; Oxygen free radical; Inflammation
Tissue damage may occur from a variety of stimuli: infections, trauma, chemical insults, radiation and lack of oxygen and nutrients. Proper healing requires a response where rapid and organized events take place involving several cellular types. Platelets, immune system cells, fibroblasts, endothelial cells and keratinocytes work in a coordinated way to restore homeostasis15.
Just after the injury, platelets are engaged in clot formation to limit blood loss and provide protection to the underlying tissues; platelets are also a reservoir for growth factors and cytokines that are released upon degranulation15,25,29. The innate immune system triggers inflammation, promoting a local infiltration of leucocytes whose major role is to kill the invading microorganisms, phagocytize cellular debris and activate keratinocytes and fibroblasts25. Sequentially, keratinokytes migrate over the injured dermis and proliferate forming a granulation tissue that intends to restore the barrier function of skin. Fibroblasts invade the clot and angiogenesis occurs. After this, in a slower process, tissue remodeling, commanded by collagen producing fibroblast, leads to scar formation25.
The occurrence of these events requires a coordinated work of a system for detection, containment, and repair of damage caused to cells. This system is composed by warning signals that initiate the process and by cells that respond to them via receptors and signaling pathways25. In this system uric acid (UA) seems to play several roles.
Uric acid is generated by the metabolism of purines in most mammals28. In lower species, allantoin is degraded by an enzyme called liver uricase resulting in very low serum uric acid levels28. However, in humans, a mutation occurred in the evolutionary scale, probably in the late Miocene, making uricase not functional28. It is believed that this selection has occurred because of the beneficial effects of uric acid as antioxidant and in the defense against tumor12. Furthermore, the UA ability to retain sodium and raise blood pressure could be considered beneficial in situations of food shortage12,28. However, with changing eating habits of the modern diet, rich in salt and uric acid precursors such as fructose, it has been observed that UA is associated with hypertension, coronary artery disease, peripheral vascular disease, renal failure and strokes8,16. Therefore uric acid appears to play a dual role in oxidative stress: antioxidant in the extracellular space and pro-oxidant within the cell4,16. UA is soluble inside cells but precipitates and readily forms monosodium urate (MSU) microcrystals in its extracellular form13.
In this review, it will explored UA action in tissue healing.
THE URIC ACID AS A WARNING SIGN
Our organism must distinguish whether their cells are alive or dead and must be able to detect when microorganisms intrude; so, it can trigger mechanisms of defense and repair. How these mechanisms are activated and orchestrated is still incompletely understood, but we know that a series of dendritic cell receptors are responsible for initiating the process. Some of the best studied receptors are the receptor for PAMPS and DAMPS13.
PAMPs or Pathogen-Associated Molecular Patterns are a diverse set of microbial molecules which are shared by several microorganisms which are vital to their survival. PAMPs are recognized primarily through toll-like receptors (TLRs), present in the antigen presenting cell which activates both innate and adaptative immune response13.
When the injury is not caused by a pathogen but by another cause such as trauma, this process is initiated by the alarmins10,13. Thus, alarmin can be considered as the "sterile equivalent of a DAMP". The whole group of alarmins and PAMPS are recognized as DAMPS or Damage Associated Molecular Pattern13.
Alarmins are a usually a group of intracellular molecules that are rapidly released following non programmed cell death (necrosis) but not by apoptotic cells13. They activate a specific receptor expressing cell (usually a dendritic cell) and recruit the innate immune system, leading to inflammation that is a necessary event to promote tissue reconstruction10,13.
UA is considered a major alarmin released by dying cells11. This molecule stimulates the maturation of dendritic cells that trigger inflammation13. The increase of serum UA after tissue damage has been shown by Patschan et al.17, in a mice model of kidney injury induced by ischemia. They found that, after an ischemic period of 30 min, systemic UA concentration was significantly elevated but restored to normal within 1 h, indicating that this process was rapidly reversible.
THE URIC ACID AS SCAVENGER OF REACTIVE OXYGEN SPECIES
Various inflammatory cells like neutrophils, macrophages, endothelial cells and fibroblasts produce reactive oxygen species (ROS) during the process of wound healing25. ROS are all oxygen associated species that have higher oxidative potential (higher reactivity) than molecular oxygen. The main members of this group are: oxygen singlet, superoxide anion, hydrogen peroxide and hydroxyl radical (OH-)25.
Oxidants are important in wound healing21. ROS play a role potentiating the clotting process; they increase platelet recruitment and collagen induced platelet activation3,9,25. They also affect neutrophil chemotaxis and facilitate the adhesion of neutrophils and monocytes to the extracellular matrix and endothelial cells14. ROS help the re-epithelization by activating collagenase expression and mediating EGF (epidermal growth factor) signaling. Furthermore they favor angiogenesis as they enhance the affinity of FGF-2 (fibroblast growth factor) to its receptor18,21,25.
However, oxidants have to be detoxified in order to prevent damage to host cells. If the delicate equilibrium between the produced amount of oxidant and antioxidants system fails, alterations in homeostasis occur that leads to oxidative stress30.
Oxidative stress has been demonstrated in chronic wounds such as chronic venous ulcers30. Yeoh-Ellerton et al.30have proved that in local fluids from chronic venous ulcer there is high levels of 8-isoprostane that is a prostaglandin-like compound generated by the action of ROS over fatty acids from membrane phospholipids. Oxidative stress prolongs the inflammation and impairs the migration and the synthetic properties of dermal fibroblasts and keratinocytes25.
UA is a powerful scavenger of free radicals that provides 60% of free-radical scavenging capacity in plasma7. It is considered one of the most prominent antioxidants in the blood of humans and birds1,19. Some studies have shown that there is benefit of intraperitoneal or intravenous administration of UA in experimental models of several disorders that involve increased oxidative stress including multiple sclerosis5, Alzheimer's disease11, stroke31 and spinal cord injury20. Unfortunately, UA is relatively insoluble and forms toxic crystals reducing its clinical utility. Chigurupati et al.191 developed an UA analog with greater solubility and potent antioxidant activity and have demonstrated that it has a nice effect healing ulcers in animal models.
URIC ACID MOBILIZING PROGENITOR ENDOTHELIAL CELLS (EPCS)
It has been shown that UA may accelerate the recruitment of EPCs (endothelial progenitor cells)17. In a very elegant study, Patschan et al.24, using mice treated with different doses of UA, identified this molecule as a physiologic, fast-acting endogenous mediator of EPC mobilization in response to tissue ischemia. This effect was dependent of dose and duration of the elevation. These authors suggested that UA may be used for pharmacologic preconditioning of EPCs.
THE URIC ACID AND ITS ROLE IN THE ADAPTATIVE IMMUNE SYSTEM
Depletion of uric acid by allopurinol reduces the generation of immunity to transplanted cell antigens24. When UA is co-injected with antigen in vivo, it significantly enhances the generation of responses of CD8+ T cells23. It is believed that uric acid leads to an increased T cell response because of its role in the activation of presenting antigen cells23,24.
Lymphocytes play a crucial role in tumour defense by inducing cytotoxic cell death and inhibiting tumour cell proliferation and migration2. Regarding these findings, an elevated level of UA should be associated with better prognosis in cancer, which was indeed be found by Dziaman et al.6. They showed that survival time in colorectal cancer patients is higher in those with higher UA serum levels. Also, it has been displayed that elevated serum UA levels may protect against cancer mortality in a large study of 1.823 males with lung, colorectal and prostate cancer27. Nevertheless, this tumor protecting action of uric acid has not been accepted by others26.
There are several gaps in our knowledge of the UA role in the microenvironment of tissue wounds. Despite this, there are some clear suggestions that pursuing the study of the inflammatory and immunological role of this molecule may offer new ways of understanding the basis of tissue healing and how to manipulate it for the benefit of patients.
1. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981; 78: 6858-62. [ Links ]
2. Caserta S, Borger JG, Zamoyska R. Central and effector memory CD4 and CD8 T-cell responses to tumor-associated antigens. Crit Rev Immunol. 2012; 32:97-126. [ Links ]
3. Chung AW, Radomski A, Alonso-Escolano D, Jurasz P, Stewart MW, Malinski TR, et al. Platelet-leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases. Br J Pharmacol. 2004; 143: 845-55. [ Links ]
4. Daoussis D, Kitas GD. Uric acid and cardiovascular risk in rheumatoid arthritis Rheumatology 2011; 50: 1354-5. [ Links ]
5. DC, Bagasra O, Marini JC, Zborek A, Ohnishi ST, et al. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci USA 1997; 94: 2528-33. [ Links ]
6. Dziaman T, Banaszkiewicz Z, Roszkowski K, Gackowski D, Wisniewska E, Rozalski R, et al. Oxo-7,8-dihydroguanine and uric acid as efficient predictors of survival in colon cancer patients- Int J Cancer. 2014; 134: 376-83. [ Links ]
7. Fabbrini E, Serafini M, Baric IC, Hazen SL, Klein S. Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects. Diabetes 2014; 63:976-81. [ Links ]
8. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008; 359:1811-21. [ Links ]
9. Herkert O, Diebold I, Brandes RP, Hess J, Busse R, Gorlach A. NADPH oxidase mediates tissue factor-dependent surface procoagulant activity by thrombin in human vascular smooth muscle cells. Circulation 2002; 105: 2030-6. [ Links ]
10. Janeway Jr CA, Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2002; 20: 197-216. [ Links ]
11. Keller JN, Kindy MS, Holtsberg FW, St Clair DK, Yen HC, et al. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 1998; 18: 687-97. [ Links ]
12. Maes BC, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant and radical causing aging and cancer. Proc Natl Acad Sci USA, 1981; 78:6658-62. [ Links ]
13. Marco E. Bianchi. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007; 81:1-5. [ Links ]
14. Nakamura H, Herzenberg LA, Bai J, Araya S, Kondo N, Nishinaka Y, Yodoi J. Circulating thioredoxin suppresses lipopolysaccharide induced neutrophil chemotaxis. Proc Natl Acad Sci USA 2001; 98: 15143-8. [ Links ]
15. Ostvar O, Shadvar S, Yahaghi E, Azma K, Fayyaz AF, Ahmadi K et al. Effect of platelet-rich plasma on the healing of cutaneous defects exposed to acute to chronic wounds: a clinico-histopathologic study in rabbits. Diagn Pathol. 2015; 10:85-91. [ Links ]
16. Panoulas VF, Milionis HJ, Douglas KM, Nightingale P, Kita MD, Klocke R, et al. Association of serum uric acid with cardiovascular disease in rheumatoid arthritis. Rheumatology 2007; 46: 1466-70. [ Links ]
17. Patschan D, Patschan S, Gobe GG, Chintala S, Goligorsky MS. Uric acid heralds ischemic tissue injury to mobilize endothelial progenitor cells. J Am Soc Nephrol. 2007; 18:1516-24 [ Links ]
18. Peus D, Vasa RA, Meves A, Pott M, Beyerle A, Squillace K, Pittelkow MR. H2O2 is an important mediator of UVB-induced EGF-receptor phosphorylation in cultured keratinocytes. J Invest Dermatol. 1998; 110: 966-71. [ Links ]
19. S, Mughal MR, Chan SL, Arumugam TV, Baharani A, Tang SC, et al. A synthetic uric acid analog accelerates cutaneous wound healing in mice. PLoS One. 2010 6;5:e10044. [ Links ]
20. Scott GS, Cuzzocrea S, Genovese T, Koprowski H, Hooper DC. Uric acid protects against secondary damage after spinal cord injury. Proc Natl Acad Sci USA 2005; 102: 3483-8. [ Links ]
21. Sen CK. The general case for redox control in wound repair. Wound Rep Reg, 2003; 11: 431-438. [ Links ]
22. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425: 516-21. [ Links ]
23. Shi Y, Galusha SA, Rock KL. Cutting edge: elimination of an endogenous adjuvant reduces the activation of CD8 T lymphocytes to transplanted cells and in an autoimmune diabetes model. J Immunol. 2006; 176: 3905-8. [ Links ]
24. Shi Y, Zheng W, Rock KL. Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc Natl Acad Sci USA. 2000; 97: 14590-5. [ Links ]
25. Soneja A, Drews M, Malinski T. Role of nitric oxide, nitroxidative and oxidative stress in wound healing. Pharmacol Rep. 2005; 57 Suppl:108-19. [ Links ]
26. Stotz M, Szkandera J, Seide J, Stojakovic T, Samonigg H, Reitz D, et al. Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients. PLoS One. 2014; 9: e104730. [ Links ]
27. Taghizadeh N, Vonk JM, Boezen HM.Serum uric acid levels and cancer mortality risk among males in a large general population-based cohort study. Cancer Causes Control. 2014 ; 25: 1075-80. [ Links ]
28. Watanabe S, Kang DH, Feng L, Nakagawa T, Kanellis J, Lan H, et al. Uric acid,hominoid evolution and the pathogenesis of salt hypersensitivity. Hypertension 2002; 40: 355-60. [ Links ]
29. Weibric G, Buch RS, Kleis WK, Hafner G, Hitzler WE, Wagner W. Quantification of thrombocyte growth factors in platelet concentrates produced by discontinuous cell separation. Growth Factors. 2002; 20:93-7. [ Links ]
30. Yeoh-Ellerton S, Stacey MC. Iron and 8-isoprostane levels in acute and chronic wounds. J Invest Dermatol. 2003 ; 121: 918-25. [ Links ]
31. Yu ZF, Bruce-Keller AJ, Goodman Y, Mattson MP. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res 1998; 53: 613-25. [ Links ]
Financial source: none
Correspondence: Thelma L Skare E mail: email@example.com
Conflicts of interest: none
01318-901 São Paulo/SP Brasil
Tel.: (11) 3288-8174/3289-0741